YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [http…
An updated edition of the June 2, 2026, article. Genomics is a broad and detailed study of genomes (an organism's complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this area have heightened interest from pharmace…
Is TVTX a good stock to buy? We came across a bullish thesis on Travere Therapeutics, Inc. on Biotech Distilled's Substack. In this article, we will summarize the bulls' thesis on TVTX. Travere Therapeutics, Inc.'s share was trading at $47…
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics…
[Financial market sector Healthcare on blue finance background from graphs, charts. 3D render] Vladimir Zakharov A screen of U.S. healthcare stocks with market capitalizations between $300M and $2B highlights several small-cap companies, i…
SEATTLE, May 27, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor con…
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best stocks under $5 with huge upside potential. Wedbush lifted the price target on Sana Biotechnology, Inc. (NASDAQ:SANA) to $7 from $6 on April 14, reaffirming an Outperform rating on…
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy according to hedge funds. On March 16, H.C. Wainwright reiterated Sana Biotechnology (NASDAQ:SANA) as a Buy with a $7 price target.Sana Biotechnology…
(RTTNews) - Sana Biotechnology Inc. (SANA), a company developing engineered cell therapies, announced on Monday a strategic collaboration with Mayo Clinic for developing SC451, an investigational pancreatic islet cell therapy to treat Type…
Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will include processes and protocols to impro…
Health care stocks were mixed late Friday afternoon, with the NYSE Health Care Index gaining 0.2% an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Health care stocks rose Friday afternoon, with the NYSE Health Care Index increasing 0.3% and the St PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
(RTTNews) - Sana Biotechnology, Inc. (SANA) reported fourth-quarter financial results with an expanded net loss. But on an adjusted basis, the net loss narrowed. In addition, the firm provided details on the upcoming milestones and its cas…
We came across a bullish thesis on Sana Biotechnology, Inc. on Stock Invader’s Substack. In this article, we will summarize the bulls’ thesis on SANA. Sana Biotechnology, Inc.'s share was trading at $4.00 as of February 9th.Why Impact Biom…
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana Biotechnology appointed Brian Piper as Executive Vice President and Chief Financial Officer. Brian Piper joined the compa…
An updated edition of the Jan. 6, 2026, article. Genomics is the comprehensive study of genomes—the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this field has intensified interest among phar…
Sana Biotechnology, Inc SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presenta…
SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual…
An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this area have heightened interest from pharmac…
Key Points Nextdoor is an online forum geared toward local communities and neighborhoods. Eric Jackson of EMJ Capital says Nextdoor could be an untapped agentic AI stock. While Jackson's ideas make sense in theory, a lot needs to go right…
Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine Models Using Fusogen Technology Broadens Application of Fusogen Technology Beyond T Cells to Se…
We recently published 10 Small Stocks with Mighty Gains. Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the top-performing stocks on Wednesday. Sana Biotechnology soared by 14.53 percent on Wednesday to finish at $4.02 apiece as investor…
SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor co…
Issued on behalf of Avant Technologies Inc. VANCOUVER, British Columbia, Nov. 19, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies race…
An updated edition of the Sept. 18, 2025, article. Genomics is a comprehensive study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Given the recent promising breakthroughs in this field, the space is drawing inte…
Sana Biotechnology Inc. (NASDAQ:SANA) is a must-buy penny stock according to analysts. On November 7, Bank of America Securities analyst Alec Stranahan reaffirmed a Buy rating on Sana Biotechnology (NASDAQ: SANA) and set a price target of…
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied…
Yahoo Finance anchor Julie Hyman tracks Wednesday's top moving stocks and biggest market stories in this Market Minute. Gold (GC=F) notched yet another record high at $4,200. Progressive (PGR) stock is sinking after the company reported th…
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Dragon Claws/iStock via Getty Images Shares of Sana Biotechnology (NASDAQ:SANA [https://seekingalpha.com…
We came across a bullish thesis on TruBridge, Inc. (TBRG) on Negócios pelo Mundo’s Substack by Leo Caroli. In this article, we will summarize the bulls’ thesis on TBRG. TruBridge, Inc. (TBRG)'s share was trading at $21.79 as of September 1…
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy now. On September 5, the company confirmed the retirement of Executive Vice President Bernard J. Cassidy, effective October 20, 2025.Sana Biotechnolog…
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to buy right now. The company develops next-generation cell and gene therapies, including ex vivo engineered cells and in vivo delivery technologies. Its f…
Savvy investors do not always chase expensive stocks to find high-growth opportunities. In fact, some of the most exciting plays in the market trade lower than $10, offering investors the chance to multiply their money over time if the und…
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the Top 10 Stocks Under $10 That Could Triple. On August 21, JMP Securities reaffirmed its Market Outperform rating for Sana Biotechnology, Inc. (NASDAQ:SANA) with a price target of $5. This…
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the biop…